Author

Thomas Hsu

National Institute of Allergy and Infectious Diseases

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell signaling & trafficking· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Assay:metabolomics· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Adam HageiD· 1 shared Alison W. AshbrookiD· 1 shared Benjamin H. SchwarziD· 1 shared Byron ShueiD· 1 shared Catharine M. BosioiD· 1 shared Charles L. LarsoniD· 1 shared Charles M. RiceiD· 1 shared Douglas C. WallaceiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Adam HageORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Mitochondrial Hyperactivity and Reactive Oxygen Species Drive Innate Immunity to the Yellow Fever Virus-17D Live-Attenuated Vaccine

Samantha G. Muccilli, Benjamin H. Schwarz, Byron Shue, Forrest Jessop, Jeffrey G. Shannon, Charles L. Larson, Adam Hage, Seon-Hui Hong, Eric Bohrnsen, Thomas Hsu, Alison W. Ashbrook, Gail L. Sturdevant, Shelly J. Robertson, Joseph W. Guarnieri, Justin Lack, , Sonja M. Best

This study identifies mitochondrial hyperactivity and reactive oxygen species as critical drivers of innate immunity to the YFV-17D vaccine, enhancing IFN response and vaccine effectiveness.

PLoS Pathogens · Apr 21, 2025Peer-reviewedImmunology